423 related articles for article (PubMed ID: 15135892)
1. Comparative effects of huperzine A, donepezil and rivastigmine on cortical acetylcholine level and acetylcholinesterase activity in rats.
Liang YQ; Tang XC
Neurosci Lett; 2004 May; 361(1-3):56-9. PubMed ID: 15135892
[TBL] [Abstract][Full Text] [Related]
2. Comparative studies of huperzine A, donepezil, and rivastigmine on brain acetylcholine, dopamine, norepinephrine, and 5-hydroxytryptamine levels in freely-moving rats.
Liang YQ; Tang XC
Acta Pharmacol Sin; 2006 Sep; 27(9):1127-36. PubMed ID: 16923332
[TBL] [Abstract][Full Text] [Related]
3. N1phenethyl-norcymserine, a selective butyrylcholinesterase inhibitor, increases acetylcholine release in rat cerebral cortex: a comparison with donepezil and rivastigmine.
Cerbai F; Giovannini MG; Melani C; Enz A; Pepeu G
Eur J Pharmacol; 2007 Oct; 572(2-3):142-50. PubMed ID: 17643410
[TBL] [Abstract][Full Text] [Related]
4. Effects of huperzine A on acetylcholinesterase isoforms in vitro: comparison with tacrine, donepezil, rivastigmine and physostigmine.
Zhao Q; Tang XC
Eur J Pharmacol; 2002 Nov; 455(2-3):101-7. PubMed ID: 12445575
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.
Duysen EG; Li B; Darvesh S; Lockridge O
Toxicology; 2007 Apr; 233(1-3):60-9. PubMed ID: 17194517
[TBL] [Abstract][Full Text] [Related]
6. Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease.
Kaasinen V; Någren K; Järvenpää T; Roivainen A; Yu M; Oikonen V; Kurki T; Rinne JO
J Clin Psychopharmacol; 2002 Dec; 22(6):615-20. PubMed ID: 12454562
[TBL] [Abstract][Full Text] [Related]
7. Effect of donepezil hydrochloride (E2020) on basal concentration of extracellular acetylcholine in the hippocampus of rats.
Kosasa T; Kuriya Y; Matsui K; Yamanishi Y
Eur J Pharmacol; 1999 Sep; 380(2-3):101-7. PubMed ID: 10513568
[TBL] [Abstract][Full Text] [Related]
8. Donepezil induces a cholinergic sprouting in basocortical degeneration.
Ginestet L; Ferrario JE; Raisman-Vozari R; Hirsch EC; Debeir T
J Neurochem; 2007 Jul; 102(2):434-40. PubMed ID: 17394553
[TBL] [Abstract][Full Text] [Related]
9. Effect of subchronic administration of metrifonate, rivastigmine and donepezil on brain acetylcholine in aged F344 rats.
Scali C; Casamenti F; Bellucci A; Costagli C; Schmidt B; Pepeu G
J Neural Transm (Vienna); 2002 Jul; 109(7-8):1067-80. PubMed ID: 12111444
[TBL] [Abstract][Full Text] [Related]
10. Effect of donepezil hydrochloride (E2020) on extracellular acetylcholine concentration in the cerebral cortex of rats.
Kosasa T; Kuriya Y; Yamanishi Y
Jpn J Pharmacol; 1999 Oct; 81(2):216-22. PubMed ID: 10591480
[TBL] [Abstract][Full Text] [Related]
11. Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: a microdialysis study.
Shearman E; Rossi S; Szasz B; Juranyi Z; Fallon S; Pomara N; Sershen H; Lajtha A
Brain Res Bull; 2006 Mar; 69(2):204-13. PubMed ID: 16533671
[TBL] [Abstract][Full Text] [Related]
12. A multinational, randomised, 12-week, comparative study of donepezil and rivastigmine in patients with mild to moderate Alzheimer's disease.
Wilkinson DG; Passmore AP; Bullock R; Hopker SW; Smith R; Potocnik FC; Maud CM; Engelbrecht I; Hock C; Ieni JR; Bahra RS
Int J Clin Pract; 2002; 56(6):441-6. PubMed ID: 12166542
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of nicotinic acetylcholine receptors by central-type acetylcholinesterase inhibitors in rat cortical neurons.
Kume T; Sugimoto M; Takada Y; Yamaguchi T; Yonezawa A; Katsuki H; Sugimoto H; Akaike A
Eur J Pharmacol; 2005 Dec; 527(1-3):77-85. PubMed ID: 16313899
[TBL] [Abstract][Full Text] [Related]
14. Reversible and persistent decreases in cocaine self-administration after cholinesterase inhibition: different effects of donepezil and rivastigmine.
Grasing K; Yang Y; He S
Behav Pharmacol; 2011 Feb; 22(1):58-70. PubMed ID: 22173266
[TBL] [Abstract][Full Text] [Related]
15. Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period.
Bullock R; Touchon J; Bergman H; Gambina G; He Y; Rapatz G; Nagel J; Lane R
Curr Med Res Opin; 2005 Aug; 21(8):1317-27. PubMed ID: 16083542
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of orally administered donepezil hydrochloride (E2020), a novel treatment for Alzheimer's disease, on cholinesterase activity in rats.
Kosasa T; Kuriya Y; Matsui K; Yamanishi Y
Eur J Pharmacol; 2000 Feb; 389(2-3):173-9. PubMed ID: 10688981
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and evaluation of novel heterodimers of donepezil and huperzine fragments as acetylcholinesterase inhibitors.
Hu Y; Zhang J; Chandrashankra O; Ip FC; Ip NY
Bioorg Med Chem; 2013 Feb; 21(3):676-83. PubMed ID: 23273608
[TBL] [Abstract][Full Text] [Related]
18. Brain levels and acetylcholinesterase inhibition with galantamine and donepezil in rats, mice, and rabbits.
Geerts H; Guillaumat PO; Grantham C; Bode W; Anciaux K; Sachak S
Brain Res; 2005 Feb; 1033(2):186-93. PubMed ID: 15694923
[TBL] [Abstract][Full Text] [Related]
19. Anticholinesterase effects of huperzine A, E2020, and tacrine in rats.
Wang H; Tang XC
Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):27-30. PubMed ID: 10375753
[TBL] [Abstract][Full Text] [Related]
20. Comparison of donepezil-, tacrine-, rivastigmine- and metrifonate-induced central and peripheral cholinergically mediated responses in the rat.
Dronfield S; Egan K; Marsden CA; Green AR
J Psychopharmacol; 2000; 14(3):275-9. PubMed ID: 11106308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
